Repligen Corporation (RGEN) 의 후행 P/E는 134.9, 선행 P/E 65.8. 후행 이익수익률은 0.74%, 선행 이익수익률 1.52%. PEG 0.50 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $26.93.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 61/100 1/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 88.6 | 3.54 | 6.13 | 9.90 | - |
| 2017 | 48.9 | 0.44 | 2.34 | 9.82 | - |
| 2018 | 138.9 | -2.86 | 3.75 | 11.90 | - |
| 2019 | 208.9 | 13.23 | 4.22 | 16.55 | - |
| 2020 | 168.1 | 1.06 | 6.59 | 27.50 | - |
| 2021 | 113.6 | 1.09 | 8.33 | 21.73 | - |
| 2022 | 50.5 | 1.15 | 4.91 | 11.71 | - |
| 2023 | 281.4 | -3.48 | 5.10 | 15.84 | - |
| 2024 | -315.6 | 1.84 | 4.08 | 12.69 | - |
| 2025 | 188.5 | -0.65 | 4.38 | 12.48 | - |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $0.34 | $104.54M | $11.68M | 11.2% |
| 2017 | $0.72 | $141.24M | $28.35M | 20.1% |
| 2018 | $0.37 | $194.03M | $16.62M | 8.6% |
| 2019 | $0.44 | $270.25M | $21.41M | 7.9% |
| 2020 | $1.11 | $366.26M | $59.93M | 16.4% |
| 2021 | $2.24 | $670.53M | $128.29M | 19.1% |
| 2022 | $3.24 | $801.54M | $185.96M | 23.2% |
| 2023 | $0.63 | $632.36M | $35.6M | 5.6% |
| 2024 | $-0.46 | $634.44M | $-25.51M | -4% |
| 2025 | $0.86 | $738.26M | $48.89M | 6.6% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $1.99 | $1.97 – $2.02 | $826.95M | $816.61M – $834.66M | 11 |
| 2027 | $2.53 | $1.97 – $2.77 | $947.81M | $937.8M – $958.41M | 11 |
| 2028 | $3.31 | $2.66 – $3.81 | $1.09B | $1.09B – $1.1B | 5 |
| 2029 | $4.47 | $4.40 – $4.55 | $1.28B | $1.26B – $1.29B | 1 |
| 2030 | $5.68 | $5.58 – $5.77 | $1.47B | $1.46B – $1.49B | 1 |
